SCHEMBL20056622

SCHEMBL20056622

COc1cc(Cl)cc(-c2ccc(O)c(C)c2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.58
ABL1 P00519 5/20 0.47
ABCB1 P08183 5/20 0.47
BCR P11274 5/20 0.47
TLR8 Q9NR97 2/20 0.44
HSD17B1 P14061 3/20 0.44
HSD17B2 P37059 3/20 0.44
CYP3A4 P08684 2/20 0.42
CYP1A1 P04798 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2E1 P05181 1/20 0.42
CYP2C8 P10632 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2A6 P11509 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP4B1 P13584 1/20 0.42
CYP2B6 P20813 1/20 0.42
CYP3A5 P20815 1/20 0.42
CYP2A7 P20853 1/20 0.42
CYP3A7 P24462 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20056528 0.88 ABL1 (0.60) ESR2ABL1ABCB1BCRTLR8
SCHEMBL20056449 0.77 ESR2 (0.62) ESR2TLR8HSD17B1HSD17B2TP53
SCHEMBL31574448 0.74 HSD17B1 (0.63) ESR2HSD17B1HSD17B2CYP3A4CYP2D6
SCHEMBL675046 0.74 HSD17B1 (0.63) ESR2HSD17B1HSD17B2CYP3A4CYP2D6
SCHEMBL272034 0.74 HSD17B1 (0.68) ESR2HSD17B1HSD17B2CYP3A4CYP1A2
SCHEMBL29696046 0.74 HSD17B1 (0.68) ESR2HSD17B1HSD17B2CYP3A4CYP1A2
SCHEMBL29429121 0.74 HSD17B1 (0.68) ESR2HSD17B1HSD17B2CYP3A4CYP1A2
SCHEMBL26979937 0.74 HSD17B1 (0.68) ESR2HSD17B1HSD17B2CYP3A4CYP1A2
Hydrogen Sulfide SCHEMBL22042810 0.72 HSD17B1 (0.65) ESR2HSD17B1HSD17B2CYP3A4CYP1A2
Hydrogen Sulfide SCHEMBL6269773 0.72 HSD17B1 (0.65) ESR2HSD17B1HSD17B2CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970353-B1 MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS VERTEX PHARMA (US) 2018-04-18 EP disclosed